Skip to main content

Advertisement

SpringerLink
Log in

A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Evidence for chemotherapy-induced cognitive impairment remains inconclusive. This study was designed to determine the trajectory of cognitive function over time in women with breast cancer, who received doxorubicin and cyclophosphamide (AC) alone or followed by a taxane. Associations between changes in cognitive function and potential covariates including anxiety, depression, fatigue, hemoglobin level, menopausal status, and perception of cognitive function were evaluated.

Methods

The Repeatable Battery for the Assessment of Neuropsychological Status, Stroop Test, and Grooved Pegboard were used to assess cognitive function in a group of 71 women prior to chemotherapy, a week after completing the last cycle of AC, as well as 1 week and 6 months after the completion of all chemotherapy.

Results

Cognitive impairment was found in 23% of women prior to chemotherapy. Hierarchical linear modeling showed significant decreases after receiving chemotherapy followed by improvements 6 months after the completion of chemotherapy in the cognitive domains of visuospatial skill (p < 0.001), attention (p = 0.022), delayed memory (p = 0.006), and motor function (p = 0.043). In contrast, immediate memory, language, and executive function scores did not change over time.

Conclusion

These results suggest that having a breast cancer diagnosis may be associated with cognitive impairment. While chemotherapy may have a negative impact on cognitive function, chemotherapy-related impairments appear to be more acute than chronic side effects of therapy. Further studies are needed to provide insight into the clinical significance and potential mechanisms of cancer and treatment-related cognitive impairments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Calvio L, Peugeot M, Bruns GL et al (2010) Measures of cognitive function and work in occupationally active breast cancer survivors. J Occup Environ Med 52:219–227

    Article  PubMed  Google Scholar 

  2. Hermelink K, Untch M, Lux MP et al (2007) Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective multicenter longitudinal study. Cancer 109:1905–1913

    Article  PubMed  CAS  Google Scholar 

  3. Hurria A, Rose C, Hudis C et al (2006) Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. J Am Geriatr Soc 54:926–931

    Google Scholar 

  4. Jansen CE, Dodd MJ, Miaskowski CA et al (2008) Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide. Psychooncology 17:1189–1195

    Article  PubMed  Google Scholar 

  5. Wefel JS, Lenzi R, Theriault RL et al (2004) The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Cancer 100:2292–2299

    Article  PubMed  CAS  Google Scholar 

  6. Bender CM, Sereika SM, Berga SL et al (2006) Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology 15:422–430

    Article  PubMed  Google Scholar 

  7. Collins B, Mackenzie J, Stewart A et al (2009) Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment. Psychooncology 18:134–141

    Article  PubMed  Google Scholar 

  8. Fan HG, Houede-Tchen N, Yi QL et al (2005) Fatigue, menopausal symptoms and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol 23:8025–8032

    Article  PubMed  Google Scholar 

  9. Jenkins V, Shilling V, Deutsch G et al (2006) A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 94:828–834

    Article  PubMed  CAS  Google Scholar 

  10. Mehlsen M, Pedersen AD, Jensen AB et al (2009) No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy. Psychooncology 18:248–257

    Article  PubMed  Google Scholar 

  11. Quesnel C, Savard J, Ivers H (2009) Cognitive impairments association with breast cancer treatments: results from a longitudinal study. Breast Cancer Res Treat 116:113–123

    Article  PubMed  Google Scholar 

  12. Schagen SB, Muller MJ, Boogerd W et al (2006) Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. J Natl Cancer Inst 98:1724–1745

    Google Scholar 

  13. Tager FA, McKinley PS, Schnabel FR et al (2010) The cognitive effects of chemotherapy in post-menopausal breast cancer patients. Breast Cancer Res Treat. doi:10.1007/s10549.009.0606.8

    PubMed  Google Scholar 

  14. Reid-Arndt SA, Hsieh C, Perry MC (2010) Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer. Psychooncology 19:535–544

    Article  PubMed  Google Scholar 

  15. Jansen C, Miaskowski C, Dodd M et al (2005) Potential mechanisms for chemotherapy-induced impairments in cognitive function. Oncol Nurs Forum 32:1151–1163

    Article  PubMed  Google Scholar 

  16. Randolph C (1998) RBANS Repeatable battery for the assessment of neuropsychological status manual. The Psychological Corporation, San Antonio

    Google Scholar 

  17. Golden CJ, Freshwater SM (2002) Stroop color and word test: a manual for clinical and experimental uses. Stoelting Company, Wood Dale

    Google Scholar 

  18. Lafayette Instrument Company (2002) Grooved pegboard test user instructions. Lafayette Instrument Company, Lafayette

    Google Scholar 

  19. Cimprich B (1992) Attentional fatigue following breast cancer surgery. Res Nurs Health 15:199–207

    Article  PubMed  CAS  Google Scholar 

  20. Radloff LS (1977) The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401

    Article  Google Scholar 

  21. Spielberger CD, Gorsuch RL, Lushene R et al (1983) Manual for the State-Trait Anxiety Inventory (STAI). Consulting Psychologists Press, Palo Alto

    Google Scholar 

  22. Lee KA, Hicks G, Nino-Murcia G (1991) Validity and reliability of a scale to assess fatigue. Psychiatry Res 36:291–298

    Article  PubMed  CAS  Google Scholar 

  23. Spreen O, Strauss E (1998) A compendium of neuropsychological tests. Oxford University Press, New York

    Google Scholar 

  24. Feinstein A, Brown R, Ron M (1994) Effects of practice on serial tests of attention in healthy subjects. J Clin Exp Neuropsychol 16:436–447

    Article  PubMed  CAS  Google Scholar 

  25. Franzen MD, Tishelman AC, Sharp BH, Friedman AG (1987) An investigation of the test–retest reliability of the Stroop Color-Word Test across two intervals. Arch Clin Neuropsychol 32:654–658

    Google Scholar 

  26. Dikmen SS, Heaton RK, Grant I, Temkin NR (1999) Test-retest reliability and practice effects of Expanded Halstead-Reitan Neuropsychological Test Battery. J Int Neuropsychol Soc 5:346–356

    Article  PubMed  CAS  Google Scholar 

  27. Kelland DZ, Lewis RF (1994) Evaluation of the reliability and validity of the repeatable cognitive perceptual motor battery. Clin Neuropsychol 8:295–308

    Article  Google Scholar 

  28. Cimprich B, Visovatti M, Ronis DL (2010) The attentional function index—a self-report cognitive measure. Psychooncology. doi:10.1002/pon.1729

    PubMed  Google Scholar 

  29. Singer JD, Willett JB (2003) Applied longitudinal data analysis: modeling change and event occurrence. Oxford University Press, New York

    Google Scholar 

  30. Rothman KJ (1990) No adjustments are needed for multiple comparisons. Epidemiol 1:45–46

    Google Scholar 

Download references

Acknowledgement

We would like to acknowledge that Dr. Jansen was supported by the American Cancer Society Doctoral Scholarship in Cancer Nursing (no. 02-209-03) and a grant from the Oncology Nursing Society Foundation. Drs. Cooper, Dodd, and Miaskowski are supported by grants from the National Cancer Institute and the National Institute of Nursing Research.

Conflict of interest

None of the authors have any conflicts to disclose.

Author information

Authors and Affiliations

  1. Kaiser Permanente Medical Center, 2238 Geary Blvd., Room 8E343, San Francisco, CA, 94115, USA

    Catherine E. Jansen

  2. Department of Community Health Systems, University of California, San Francisco, USA

    Bruce A. Cooper

  3. Department of Physiological Nursing, University of California, San Francisco, USA

    Marylin J. Dodd & Christine A. Miaskowski

Authors
  1. Catherine E. Jansen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bruce A. Cooper
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marylin J. Dodd
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christine A. Miaskowski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Catherine E. Jansen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jansen, C.E., Cooper, B.A., Dodd, M.J. et al. A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer 19, 1647–1656 (2011). https://doi.org/10.1007/s00520-010-0997-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-010-0997-4

Keywords

Search

Navigation